The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis

Gastroenterology

Volumn 128, Issue 2, 2005, Pages 297-303

  Corpechot, Christophe ^a   Carrat, Fabrice ^b   Bahr, Abbas ^a   Chrétien, Yves ^c   Poupon, Renée Eugénie ^c   Poupon, Raoul ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

URSODEOXYCHOLIC ACID; CHOLAGOGUE;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DEATH; DISEASE COURSE; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROBABILITY; STATISTICAL MODEL; SURVIVAL; SURVIVAL RATE; BILIARY CIRRHOSIS; BIOLOGICAL MODEL; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS;

ADULT; AGED; CHOLAGOGUES AND CHOLERETICS; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; SURVIVAL ANALYSIS; URSODEOXYCHOLIC ACID;

EID: 14944361288     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.11.009     Document Type: Article

References (40)

1. K. Balasubramaniam, P.M. Grambsch, R.H. Wiesner, K.D. Lindor, E.R. Dickson Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study Gastroenterology 98 1990 1567 1571
2. T.C. Mahl, W. Shockcor, J.L. Boyer Primary biliary cirrhosis survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years J Hepatol 20 1994 707 713
3. W.R. Kim, K.D. Lindor, G.R. Locke III, T.M. Therneau, H.A. Homburger, K.P. Batts, B.P. Yawn, J.L. Petz, L.J. Melton III, E.R. Dickson Epidemiology and natural history of primary biliary cirrhosis in a US community Gastroenterology 119 2000 1631 1636
4. M.I. Prince, A. Chetwynd, W. Newman, J.V. Metcalf, O.F. James Survival and symptom progression in a geographically based cohort of paients with primary biliary cirrhosis follow-up for up to 28 years Gastroenterology 123 2002 1044 1051
5. E.J. Heathcote Management of primary biliary cirrhosis Hepatology 31 2000 1005 1013
6. R.E. Poupon, B. Balkau, E. Eschwege, R. Poupon UDCA-PBC Study Group A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis N Engl J Med 324 1991 1548 1554
7. K.D. Lindor, E.R. Dickson, W.P. Baldus, R.A. Jorgensen, J. Ludwig, P.A. Murtaugh, J.M. Harrison, R.H. Wiesner, M.L. Anderson, S.M. Lange Ursodeoxycholic acid in the treatment of primary biliary cirrhosis Gastroenterology 106 1994 1284 1290
8. E.J. Heathcote, K. Cauch-Dudek, V. Walker, R.J. Bailey, L.M. Blendis, C.N. Ghent, P. Michieletti, G.Y. Minuk, S.C. Pappas, L.J. Scully The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis Hepatology 19 1994 1149 1156
9. B. Combes, R.L. Carithers Jr, W.C. Maddrey, D. Lin, M.F. McDonald, D.E. Wheeler, E.H. Eigenbrodt, S.J. Munoz, R. Rubin, G. Garcia-Tsao A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis Hepatology 22 1995 759 766
10. P. Angulo, K.P. Batts, T.M. Therneau, R.A. Jorgensen, E.R. Dickson, K.D. Lindor Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis Hepatology 29 1999 644 647
11. R.E. Poupon, K.D. Lindor, A. Pares, O. Chazouilleres, R. Poupon, E.J. Heathcote Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis J Hepatol 39 2003 12 16
12. C. Corpechot, F. Carrat, A.M. Bonnand, R.E. Poupon, R. Poupon The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis Hepatology 32 2000 1196 1199
13. A. Pares, L. Caballeria, J. Rodes, M. Bruguera, L. Rodrigo, A. Garcia-Plaza, J. Berenguer, D. Rodriguez-Martinez, J. Mercader, R. Velicia Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis results of a double-blind controlled multicentric trial J Hepatol 32 2000 561 566
14. R.E. Poupon, K.D. Lindor, K. Cauch-Dudek, E.R. Dickson, R. Poupon, E.J. Heathcote Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis Gastroenterology 113 1997 884 890
15. K.D. Lindor, R. Poupon, E.J. Heathcote, T. Therneau Ursodeoxycholic acid for primary biliary cirrhosis Lancet 355 2000 657 658
16. J. Goulis, G. Leandro, A.K. Burroughs Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis a meta-analysis Lancet 354 1999 1053 1060
17. C. Gluud, E. Christensen Ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC)--a Cochrane hepato-biliary systemic review J Hepatol 30 Suppl 1 1999 83
18. M.M. Kaplan Primary biliary cirrhosis past, present, and future Gastroenterology 123 2002 1392 1394
19. C.W. Chan, G.V. Papatheodoridis, J. Goulis, A.K. Burroughs Ursodeoxycholic acid and histological progression in primary biliary cirrhosis J Hepatol 39 2003 1094 1095
20. A.K. Burroughs, G. Leandro, J. Goulis Ursodeooxycholic acid for primary biliary cirrhosis J Hepatol 34 2001 352 353
21. C. Gluud, E. Christensen Ursodeoxycholic acid for primary biliary cirrhosis lesson for the future? J Hepatol 34 2001 787 788
22. B. Combes, V.A. Luketic, M.G. Peters, R.K. Zetterman, G. Garcia-Tsao, S.J. Munoz, D. Lin, N. Flye, R.L. Carithers Jr Prolonged follow-up of patients in the U.S multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. Am J Gastroenterol 99 2004 264 268
23. R.E. Poupon Ursodeoxycholic acid for primary biliary cirrhosis lessons from the past--issues for the future J Hepatol 32 2000 685 688
24. R.L. Carithers Jr Primary biliary cirrhosis specific treatment Clin Liver Dis 7 2003 923 939
25. J.R. Beck, S.G. Pauker The Markov process in medical prognosis Med Decis Making 3 1983 419 458
26. R.C. Gentleman, J.F. Lawless, J.C. Lindsey, P. Yan Multi-state Markov models for analysing incomplete disease history data with illustrations for HIV disease Stat Med 13 1994 805 821
27. C. Corpechot, F. Carrat, R. Poupon, R. Poupon Primary biliary cirrhosis incidence and predictive factors of cirrhosis development in ursodiol-treated patients Gastroenterology 122 2002 652 658
28. G.R. Locke III, T.M. Therneau, J. Ludwig, E.R. Dickson, K.D. Lindor Time course of histological progression in primary biliary cirrhosis Hepatology 23 1996 52 56
29. R.E. Poupon, R. Poupon, B. Balkau UDCA-PBC Study Group Ursodiol for the long-term treatment of primary biliary cirrhosis N Engl J Med 330 1994 1342 1347
30. R.E. Poupon, P.M. Huet, R. Poupon, A.M. Bonnand, J.T. Nhieu, E.S. Zafrani UDCA-PBC Study Group A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis Hepatology 24 1996 1098 1103
31. J. Ludwig, E.R. Dickson, G.S. McDonald Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) Virchows Arch A Pathol Anat Histol 379 1978 103 112
32. G. Schwartz Estimating the dimension of a model Ann Stat 6 1978 461 464
33. E.R. Dickson, P.M. Grambsch, T.R. Fleming, L.D. Fisher, A. Langworthy Prognosis in primary biliary cirrhosis model for decision making Hepatology 10 1989 1 7
34. K. Lindor, T. Therneau Survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis Gastroenterology 111 1996 1782 1783
35. J. Vallin, F. Meslé Tables de mortalité françaises pour les XIXe et XXe siècles et projections pour le XXIe siècle 2001 Institut National d'Etudes Démographiques
36. G. Paumgartner, U. Beuers Ursodeoxycholic acid in cholestatic liver disease mechanisms of action and therapeutic use revisited Hepatology 36 2002 525 531
37. C. Degott, E.S. Zafrani, P. Callard, B. Balkau, R.E. Poupon, R. Poupon Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression Hepatology 29 1999 1007 1012
38. C. Corpechot, A. Poujol-Robert, D. Wendum, M. Galotte, Y. Chretien, R.E. Poupon, R. Poupon Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis Liver Int 24 2004 187 193
39. J. Roll, J.L. Boyer, D. Barry, G. Klatskin The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis N Engl J Med 308 1983 1 7
40. E. Christensen, D.G. Altman, J. Neuberger, B.L. De Stavola, N. Tygstrup, R. Williams Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model Gastroenterology 105 1993 1865 1876